News
Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...
Days after her latest “vetting” attempt was overruled at the Department of Health and Human Services, the MAGA provocateur appeared to begin her revenge tour.
The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...
17d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?
Did George Tidmarsh, MD, PhD, enter the FDA through the very revolving door its new leadership pledged to close? The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by ...
Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
By Betsy Klein, Meg Tirrell, Sarah Owermohle, Adam Cancryn, CNN (CNN) — Dr. Vinay Prasad, a controversial critic of the US Food and Drug ...
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has resigned less than three months into the job. “Dr. Prasad did ...
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the ...
The public deserves to the full story about Dr. Vinay Prasad's temporary resignation and how this might impact regulatory decisions moving forward.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results